Parvo preventative picks up speedDecember 29, 2020Elanco Animal Health is set to acquire the global rights to Kindred Biosciences’ proprietary KIND-030, a monoclonal antibody being developed for the treatment and prevention of canine parvovirus.
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
Pets, people, and planet inspire "healthy purpose" goalsOctober 28, 2020Improving human access to food resources, reducing environmental impact, and supporting the welfare of pets are the driving forces behind Elanco Animal Health’s new “healthy purpose” initiatives.
Dog parks may be petri dish for parasitesJuly 20, 2020Now more than ever, it is imperative veterinarians ensure their patients are properly protected from parasites.
$7.6-billion Elanco deal gets FTC green lightJuly 15, 2020Elanco Animal Health has received unanimous approval for its $7.6-billion acquisition of Bayer’s animal health division.
Merck snags Elanco's coccidiosis treatment for $55 millionFebruary 20, 2020Elanco Animal Health has unloaded its proprietary oral drench treatment for coccidiosis in calves and lambs to Merck Animal Health in an all-cash deal totaling $55 million.
Nutritional science central to Elanco, Purdue partnershipFebruary 13, 2020Elanco Animal Health has announced a five-year collaborative research agreement with Purdue University and Purdue Research Foundation (PRF) intended to streamline solutions for animal health-related challenges.
Elanco unloads flea treatment for $95 millionJanuary 21, 2020Elanco Animal Health has just divested its proprietary flea treatment tablets in an all-cash deal, totaling $95 million.
Elanco divests canine ear treatment in $135-million dealJanuary 6, 2020A major player in the animal health industry has just unloaded its proprietary treatment for canine otitis externa in an all-cash deal, totaling $135 million.
Aquaculture R&D firm acquires Elanco facilityDecember 24, 2019Aligning with its international restructuring plans, Elanco Animal Health has sold its aqua research and development (R&D) facility in Victoria, Prince Edward Island (PEI), Canada.
Elanco guide helps owners spot OAOctober 10, 2019Veterinarians are now better equipped to educate clients on canine osteoarthritis (OA), thanks to Elanco Animal Health.
